# The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

> **NCT03639766** · PHASE4 · TERMINATED · sponsor: **University of Central Florida** · enrollment: 3 (actual)

## Conditions studied

- Raynaud Phenomenon

## Interventions

- **DRUG:** AbobotulinumtoxinA
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT03639766
- **Lead sponsor:** University of Central Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-31
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Time and resource constraints
- **Last updated:** 2021-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03639766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03639766, "The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03639766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*